Galderma Group AG
Galderma Group AG, a leading player in the pharmaceutical preparation manufacturing industry, is headquartered in Switzerland (CH). Founded in 1981, the company has established itself as a pioneer in dermatology and aesthetic medicine, focusing on innovative solutions for skin health. With a strong presence in Europe, North America, and Asia, Galderma is renowned for its diverse portfolio, which includes products like Restylane and Dysport, designed to enhance skin appearance and treat various dermatological conditions.
Galderma's commitment to research and development has led to significant milestones, positioning it as a trusted name in the market. The company's unique formulations and dedication to safety and efficacy have garnered numerous accolades, solidifying its reputation as a leader in skin care and aesthetic treatments.
-13 vs industry average
Galderma Group AG’s score of 25 is lower than 39% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Galderma Group AG?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2026
Reported emissions
Scope 3 accounts for ••• of total emissions.
Galderma Group AG's reported carbon emissions
Galderma Group AG, a Pharmaceutical Preparation Manufacturing company headquartered in Switzerland (CH), reported a total of approximately 345.3 million kg CO2e for the year 2023. This figure encompasses Scope 1, Scope 2, and Scope 3 emissions. For the 2023 reporting period, Galderma's Scope 1 emissions were approximately 7.6 million kg CO2e. Scope 2 emissions were approximately 5.5 million kg CO2e (location-based) or approximately 0.7 million kg CO2e (market-based). Scope 3 emissions accounted for approximately 332.1 million kg CO2e. In 2022, Galderma reported total emissions of approximately 341.9 million kg CO2e. Specifically, Scope 1 emissions were approximately 9.8 million kg CO2e, while Scope 2 emissions were approximately 5.6 million kg CO2e (location-based) or approximately 4.2 million kg CO2e (market-based). Scope 3 emissions for 2022 were approximately 332.1 million kg CO2e. Galderma Group AG's emissions data is not cascaded from a parent or related organisation. The company's climate commitments and reduction targets are not specified in the provided information, and there are no details on SBTi (Science Based Targets initiative) approved reductions or participation in initiatives like the Climate Pledge. The company's ESG updates and annual reports are available for further review.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Galderma Group AG’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Galderma Group AG yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Galderma Group AG
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project